Post by
jmthibs on Jul 11, 2020 11:02am
SONA vs. QDEL by the numbers - looking for feedback
I wanted to do my own DD to see how QDEL developments has impacted it's market cap rather than try and make SP predictions. Please feel free to comment or provide insights I've missed.
-Prior to the EUA of the LYRA test for COVID-19 (March 16th), they had a 3.1B cap
-March 17th close was 93.64$ or a 3.93B market cap
-May 8th, on no other news, market cap is 6.63B (based on SP of 158.60$)
-EUA granted for the POC test after close on May 8th, and market cap goes to 8.73B on Monday, May 11th. (based on SP of 208$)
-As of writing this, market cap is 10.4B (all numbers USD$ of course) based on 200M$ in revenues for Q2. This gives us a P/E ration of about 120, or Price/Sales of 18. I've not been able to find any details about sales estimates for POC tests, or pre-orders...If anyone has any, please let me know.
All this to say, the value of QDEL has gone up by 7B in the last 4 ish months, with no sales. So just imagine SONA with a more efficient, more accurate test, and "10's of millions of pre-orders" and what the possibilities for us might be.
Comment by
Cottrader on Jul 11, 2020 11:11am
with huge orders, FDA approval, nasdaq listing the upside potential to the stock being the best in class antigen test are staggering
Comment by
dart321 on Jul 11, 2020 11:44am
They are staggering but correct for amount of orders you are estimating. I suggest you up the amount of orders!!!!!!